Evidence map›Paper›PMID 41293696›Full record

ArticleBiomedical optics express2025

In-situ non-invasive detection of cellular reactive oxygen species by integrating Raman spectrum and bidirectional gated recurrent unit models.

Chuhan Zhang, Shengde Liu, Jianhui Wan, Weina Zhang, Liyun Zhong, Xiaoxu Lu

Abstract read
In one paragraph

Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chuhan ZhangGuangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China.
Shengde LiuGuangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China.
Jianhui WanKey Laboratory of Photonics Technology for Integrated Sensing and Communication of Ministry of Education, Guangdong University of Technology, Guangzhou 510006, China.
Weina ZhangKey Laboratory of Photonics Technology for Integrated Sensing and Communication of Ministry of Education, Guangdong University of Technology, Guangzhou 510006, China.
Liyun ZhongKey Laboratory of Photonics Technology for Integrated Sensing and Communication of Ministry of Education, Guangdong University of Technology, Guangzhou 510006, China.
Xiaoxu LuGuangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, South China Normal University, Guangzhou 510006, China.ORCID https://orcid.org/0000-0001-6757-6061

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular reactive oxygen species (ROS), a key parameter involved in cell metabolism, signaling, and apoptosis, whose detection is necessary to achieve in a variety of biological processes. However, current ROS detection methods, including fluorescence, colorimetry, and electrochemical methods, are difficult to achieve in-situ non-invasive detection due to their reliance on invasive probes or destructive sampling. In this study, we propose an in-situ non-invasive ROS detection integrating the Raman spectrum and a bidirectional gated recurrent unit (Bi-GRU) deep learning model during HepG2 cell apoptosis. The Bi-GRU model leverages bidirectional gating mechanisms to capture long-term dependencies in Raman spectra while incorporating both forward and backward spectral information for enhanced feature extraction. After training with spectral data of HepG2 cells in various apoptotic states, the R

Identifiers

PMID41293696
PMCPMC12642982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.